LifeStance Health Group Inc. (LFST)
LFST trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1845257/000119312526071462/0001193125-26-071462-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LFST on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001845257 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.4B |
| Net income | $9.7M |
| Operating income | $24.1M |
| Net margin | 0.7% |
| Operating margin | 1.7% |
| Revenue growth | +13.9% |
| Cash | $248.6M |
| Total assets | $2.2B |
| P/E (computed) | 569.7× |
| P/S (computed) | 3.9× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-05 |
| Cash and burn | $218.8M cash; operating cash flow $56.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 380,190,724 (2026-10-28); 389,000,281 a year earlier; 378,607,491 three years earlier. | Cover page 2026-10-28 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, Seattle, Washington, United States | PCAOB Form AP 2026-03-18 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $843.9M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $455.9M | $22.4M | $37.0M | $218.8M | $271.9M | $1.7B | 10-Q 2026-11-05 |
| Q2 2026 2026-06-30 | $435.4M | $23.6M | $99.9M | $225.9M | $275.5M | $1.6B | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $403.5M | $14.2M | $33.1M | $194.8M | $282.8M | $1.5B | 10-Q 2026-05-07 |
| Q4 2025 2025-12-31 | $382.2M | $11.7M | $57.6M | $248.6M | $282.8M | $1.4B | 10-K 2026-02-25 |
| Q3 2025 2025-09-30 | $363.8M | $1.1M | $27.3M | $203.9M | $284.6M | $1.4B | 10-Q 2026-11-05 |
| Q2 2025 2025-06-30 | $345.3M | -$3.8M | $64.4M | $188.9M | $286.4M | $1.3B | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $333.0M | $709K | -$3.1M | $134.3M | $288.2M | $1.3B | 10-Q 2026-05-07 |
| Q4 2024 2024-12-31 | $325.5M | -$7.1M | $62.3M | $154.6M | $290.0M | $1.3B | 10-K 2026-02-25 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B7 | 2026-11-10 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-11-05 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-04-22 |
Source: SEC EDGAR submissions feed, 519 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.3% |
| 1 month | +14.3% |
| 3 months | +15.2% |
| Year to date | +100.0% |
| 1 year | +123.1% |
| From 52-week high | -3.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| OPCH | Option Care Health Inc. | $31.71 | +0.19% | $4.8B |
| HIMS | Hims & Hers Health Inc. | $18.56 | -5.93% | $4.4B |
| CHE | Chemed Corp | $549.45 | +0.36% | $7.2B |
| PRVA | Privia Health Group Inc. | $25.26 | +2.89% | $3.2B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| BTSG | BrightSpring Health Services Inc. | $71.37 | +0.22% | $14.2B |
| TDOC | Teladoc Health Inc. | $8.70 | -1.14% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier